[DPHARMA] QoQ TTM Result on 31-Dec-2020 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- 7.64%
YoY- 6.04%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 627,817 589,751 577,643 569,902 573,571 582,654 584,789 4.84%
PBT 86,327 82,412 81,606 76,157 69,625 70,825 69,750 15.26%
Tax -20,167 -19,088 -18,943 -17,547 -15,175 -15,643 -15,381 19.77%
NP 66,160 63,324 62,663 58,610 54,450 55,182 54,369 13.96%
-
NP to SH 66,160 63,324 62,663 58,610 54,450 55,182 54,369 13.96%
-
Tax Rate 23.36% 23.16% 23.21% 23.04% 21.80% 22.09% 22.05% -
Total Cost 561,657 526,427 514,980 511,292 519,121 527,472 530,420 3.88%
-
Net Worth 612,147 614,350 635,424 642,484 584,565 581,725 540,662 8.62%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 45,892 45,892 45,783 45,783 37,536 37,536 40,733 8.26%
Div Payout % 69.37% 72.47% 73.06% 78.12% 68.94% 68.02% 74.92% -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 612,147 614,350 635,424 642,484 584,565 581,725 540,662 8.62%
NOSH 941,765 706,330 706,026 706,026 706,026 684,383 684,383 23.69%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 10.54% 10.74% 10.85% 10.28% 9.49% 9.47% 9.30% -
ROE 10.81% 10.31% 9.86% 9.12% 9.31% 9.49% 10.06% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 66.66 83.52 81.82 80.72 82.42 85.14 85.45 -15.24%
EPS 7.03 8.97 8.88 8.30 7.82 8.06 7.94 -7.78%
DPS 4.87 6.50 6.48 6.48 5.50 5.50 5.95 -12.48%
NAPS 0.65 0.87 0.90 0.91 0.84 0.85 0.79 -12.18%
Adjusted Per Share Value based on latest NOSH - 706,026
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 65.22 61.26 60.01 59.20 59.58 60.53 60.75 4.84%
EPS 6.87 6.58 6.51 6.09 5.66 5.73 5.65 13.90%
DPS 4.77 4.77 4.76 4.76 3.90 3.90 4.23 8.33%
NAPS 0.6359 0.6382 0.6601 0.6674 0.6072 0.6043 0.5616 8.62%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 1.81 3.03 2.75 3.38 3.16 1.62 1.39 -
P/RPS 2.72 3.63 3.36 4.19 3.83 1.90 1.63 40.64%
P/EPS 25.76 33.79 30.98 40.72 40.39 20.09 17.50 29.37%
EY 3.88 2.96 3.23 2.46 2.48 4.98 5.72 -22.78%
DY 2.69 2.15 2.36 1.92 1.74 3.40 4.28 -26.60%
P/NAPS 2.78 3.48 3.06 3.71 3.76 1.91 1.76 35.59%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 18/11/21 17/08/21 03/05/21 22/02/21 12/11/20 13/08/20 18/05/20 -
Price 1.62 2.49 2.93 3.42 4.04 3.15 1.72 -
P/RPS 2.43 2.98 3.58 4.24 4.90 3.70 2.01 13.47%
P/EPS 23.06 27.77 33.01 41.20 51.63 39.07 21.65 4.29%
EY 4.34 3.60 3.03 2.43 1.94 2.56 4.62 -4.07%
DY 3.01 2.61 2.21 1.90 1.36 1.75 3.46 -8.86%
P/NAPS 2.49 2.86 3.26 3.76 4.81 3.71 2.18 9.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment